Task: Answer the multiple choice question.
Query: Which drug exhibits a 15.794\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
[a] CCOC(=O)c1c(CN2CCOCC2)oc2ccc(OC)cc12
[b] Cc1cccc(Nc2nc(N)c([N+](=O)[O-])c(N3CCCC(C)C3)n2)c1
[c] CCCCN(C(=O)CN1C(=O)C2CCCCC2C1=O)c1c(N)n(CCC)c(=O)[nH]c1=O
[d] S=c1[nH]nc(C2CCCCC2)n1Cc1ccccc1
[e] O=C(Nc1nc2ccccc2c(=O)s1)c1ccco1
Answer: c. CCCCN(C(=O)CN1C(=O)C2CCCCC2C1=O)c1c(N)n(CCC)c(=O)[nH]c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(C(=O)CN1C(=O)C2CCCCC2C1=O)c1c(N)n(CCC)c(=O)[nH]c1=O
CCCCN(C(=O)CN1C(=O)C2CCCCC2C1=O)c1c(N)n(CCC)c(=O)[nH]c1=O
N-(6-amino-2,4-dioxo-1-propylpyrimidin-5-yl)-N-butyl-2-(1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-2-yl)acetamide